cerrar
Tagged with Oncology

Stefanie Granado – Director General Iberia, Takeda
Stefanie Granado, director general of Takeda Iberia recounts the opportunities available for Takeda in Spain following its acquisition of Shire. She…

Tse Wen Chang – Founder & President, Immunwork, Taiwan
Dr Tse Wen Chang, founder of Immunwork, gives an update on the preclinical development process of the company’s revolutionary T-E pharmaceutical…

James Chih-Hsin Yang – Director, Department of Oncology,…
Dr James Chih-Hsin Yang, director of National Taiwan University Hospital’s department of oncology, speaks about oncology in Taiwan and the role that…

Mohamed Khattab – Chairman and Managing Director, Sedico,…
Dr Mohamed Khattab, the newly appointed chairman and managing director of Sedico, lifts the lid on his vision for the company being a leader in…

Chinese PD-1 Cancer Drugs: Global Competition for Big Pharma
PD-1 inhibitors have boosted survival rates for many cancer patients since their introduction in the US five years ago. Last year, MSD and BMS began…

Carsten Lu – CEO, Adlai Nortye, China
Carsten Lu of Chinese biotech Adlai Nortye outlines his strategy for navigating a crowded immuno-oncology field in China, his partnership strategy,…

Éric Ducournau – CEO, Pierre Fabre Group
Éric Ducournau, global CEO of Pierre Fabre Group, the second largest dermo-cosmetic company worldwide and the third-largest French pharmaceutical…

Grace Yeh – President and Founder, PharmaEngine, Inc.,…
Grace Yeh, president and founder of PharmaEngine, gives an update on the company’s recent growth and development of their second nanomedicine cancer…

East vs West: Bridging the Access Gap in European Cancer Care
From her vantage point as associate vice president for MSD's Central & Eastern Europe (CEE) cluster, Gabriele Grom outlines the disparity that…

Ines Perea – General Manager, Jazz Pharmaceuticals Spain…
Ines Perea, general manager for Spain and Portugal at Jazz Pharmaceuticals, a global biopharmaceutical company dedicated to developing life-changing…

Is CNS the Next Oncology?
Cerecin's Charles Stacey looks at the large unmet medical need in diseases of the central nervous system (CNS), the looming socioeconomic burden that…

Franck Cousserans – General Manager France & Belgium,…
Franck Cousserans, general manager of France and Belgium at Jazz Pharmaceuticals, highlights the company’s key products and the challenges of market…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here